This is supported by evidence that AR expression is preserved in most prostate cancer specimens, regardless of the stage and grade, and by the fact that only a small proportion of CRCP patients experience loss of AR expression, presumably through AR promoter methylation [10]. This evidence concerns the gene AR and Familial prostate cancer.